Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy

NCT01292070 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

4

Enrollment

NIH

Sponsor class

Stopped Futility

Conditions

Cat Allergy

Interventions

BIOLOGICAL: Intradermal Human Fcγ1-Fel d1 fusion protein
BIOLOGICAL: Positive Control - standardized cat hair allergenic extract (CAT)
BIOLOGICAL: Positive Control - Histamine Prick
BIOLOGICAL: Negative Control - Intradermal Diluent

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]